Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2015 Jul-Aug;21(4):269-70.
doi: 10.5152/dir.2015.001.

Gadolinium deposition in the brain: another concern regarding gadolinium-based contrast agents

Affiliations
Editorial

Gadolinium deposition in the brain: another concern regarding gadolinium-based contrast agents

Nevzat Karabulut. Diagn Interv Radiol. 2015 Jul-Aug.
No abstract available

PubMed Disclaimer

References

    1. Karabulut N, Elmas N. Contrast agents used in MR imaging of the liver. Diagn Interv Radiol. 2006;12:22–30. - PubMed
    1. Grobner T. Gadolinium—a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant. 2006;21:1104–1108. http://dx.doi.org/10.1093/ndt/gfk062. - DOI - PubMed
    1. Marckmann P, Skov L, Rossen K, et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol. 2006;17:2359–2362. http://dx.doi.org/10.1681/ASN.2006060601. - DOI - PubMed
    1. Aydingöz U. The need for radiologists’ awareness of nephrogenic systemic fibrosis. Diagn Interv Radiol. 2006;12:161–162. - PubMed
    1. Martin DR, Krishnamoorthy SK, Kalb B, et al. Decreased incidence of NSF in patients on dialysis after changing gadolinium contrast-enhanced MRI protocols. J Magn Reson Imaging. 2010;31:440–446. http://dx.doi.org/10.1002/jmri.22024. - DOI - PMC - PubMed

Publication types

MeSH terms